Santiago Roura

Associate Professor

Universitat de Vic - Universitat Central de Catalunya

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Tissue Engineering Tissue Engineering professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Santiago Roura is an Associate Professor at Universitat de Vic - Universitat Central de Catalunya in Spain. His research primarily focuses on cardiovascular diseases, including studies on Empagliflozin and Sacubitril/Valsartan in relation to myocardial infarction and hypertrophic cardiomyopathy. Additionally, he has explored the implications of soluble mutant huntingtin in Huntington's disease and the interaction of extracellular vesicles in endothelial cell activation.

Articles (16)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (7)

Oriol Iborra Egea

Chief Executive Officer

NIMBLE Diagnostics, S.L

SPAIN

View details

Josep M. Canals

Full Professor

University of Barcelona

SPAIN

View details

Nirmal Vadgama

Lecturer

University of Northampton

UNITED KINGDOM

View details

FRANCESC E. BORRAS

Associate Professor

University of Barcelona

SPAIN

View details

Nicholas Allen

Professor

Cardiff University

UNITED KINGDOM

View details

Planavila Porta Anna

Associate professor

University of Barcelona

SPAIN

View details

Albert Teis

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Santiago Roura

Research Interests

Explore related searches

Contact this professor

About

Articles (16)

Initiating Empagliflozin and Sacubitril/Valsartan Early After Acute Myocardial Infarction: Mechanistic Study

Empagliflozin Attenuates Arrhythmias in an iPSC-Based Model of Hypertrophic Cardiomyopathy

Antiarrhythmic and Anti-Inflammatory Effects of Sacubitril/Valsartan on Post-Myocardial Infarction Scar

Implantation of a double allogeneic human engineered tissue graft on damaged heart: insights from the PERISCOPE phase I clinical trial

Meteorin-like protein is associated with a higher risk profile and predicts a worse outcome in patients with STEMI

Soluble mutant huntingtin drives early human pathogenesis in Huntington’s disease

Soluble mutant huntingtin drives early human pathogenesis in Huntington's disease

Preclinical scenario of targeting myocardial fibrosis with chimeric antigen receptor (CAR) immunotherapy

Electrophysiological effects of adipose graft transposition procedure (AGTP) on the post-myocardial infarction scar: A multimodal characterization of arrhythmogenic substrate

N-Glycans in Immortalized Mesenchymal Stromal Cell-Derived Extracellular Vesicles Are Critical for EV–Cell Interaction and Functional Activation of Endothelial Cells

Commonly used methods for extracellular vesicles’ enrichment: Implications in downstream analyses and use

Human pericardial extracellular matrix: An implantation platform for cardiac tissue engineering

Acellular cardiac scaffolds enriched with MSC-derived extracellular vesicles limit ventricular remodelling and exert local and systemic immunomodulation in a myocardial infarction porcine model

Circulating virome and inflammatory proteome in patients with ST-elevation myocardial infarction and primary ventricular fibrillation

Mechanisms governing the therapeutic effect of mesenchymal stromal cell-derived extracellular vesicles: A scoping review of preclinical evidence

Clinical translation of mesenchymal stromal cell extracellular vesicles: Considerations on scientific rationale and production requisites

Collaborators (7)

Oriol Iborra Egea

Josep M. Canals

Nirmal Vadgama

FRANCESC E. BORRAS

Nicholas Allen

Planavila Porta Anna

Albert Teis

Make your next move.